Boule Diagnostics AB (publ) (STO: BOUL)
Sweden
· Delayed Price · Currency is SEK 6.78
+0.04 (0.59%)
Nov 19, 2024, 4:29 PM CET
Boule Diagnostics AB Revenue
Boule Diagnostics AB had revenue of 130.40M SEK in the quarter ending September 30, 2024, a decrease of -6.59%. This brings the company's revenue in the last twelve months to 563.33M, down -1.58% year-over-year. In the year 2023, Boule Diagnostics AB had annual revenue of 571.33M with 4.24% growth.
Revenue (ttm)
563.33M
Revenue Growth
-1.58%
P/S Ratio
0.47
Revenue / Employee
2.82M
Employees
228
Market Cap
264.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 571.33M | 23.24M | 4.24% |
| Dec 31, 2022 | 548.09M | 84.74M | 18.29% |
| Dec 31, 2021 | 463.34M | 62.89M | 15.70% |
| Dec 31, 2020 | 400.46M | -98.46M | -19.73% |
| Dec 31, 2019 | 498.92M | 74.52M | 17.56% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 519.35B |
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.17B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Vitrolife AB (publ) | 3.56B |
| Medicover AB (publ) | 22.60B |
| Elekta AB (publ) | 18.12B |
Boule Diagnostics AB News
- 24 days ago - Q3 2024 Boule Diagnostics AB Earnings Call Transcript - GuruFocus